Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country

Vista sencilla de Ć­tem
dc.contributor.authorRodriguez-Martinez, C.E.
dc.contributor.authorSossa-BriceƱo, M.P.
dc.contributor.authorCastro-Rodriguez, J.A.
dc.date.accessioned2020-05-12T21:05:52Z
dc.date.available2020-05-12T21:05:52Z
dc.date.issued2020
dc.description.abstractenglishINTRODUCTION AND OBJECTIVES: With the aim of making informed decisions on resource allocation, there is a critical need for studies that provide accurate information on hospital costs for treating pediatric asthma exacerbations, mainly in middle-income countries (MICs). The aim of the present study was to evaluate the direct medical costs associated with pediatric asthma exacerbations requiring hospital attendance in Bogota, Colombia. PATIENTS AND METHODS: We reviewed the available electronic medical records (EMRs) for all pediatric patients who were admitted to the Fundacion Hospital de La Misericordia with a discharge principal diagnosis pediatric asthma exacerbation over a 24-month period from January 2016 to December 2017. Direct medical costs of pediatric asthma exacerbations were retrospectively collected by dividing the patients into four groups: those admitted to the emergency department (ED) only; those admitted to the pediatric ward (PW); those admitted to the pediatric intermediate care unit (PIMC); and those admitted to the pediatric intensive care unit (PICU). RESULTS: A total of 252 patients with a median (IQR) age of 5.0 (3.0-7.0) years were analyzed, of whom 142 (56.3%) were males. Overall, the median (IQR) cost of patients treated in the ED, PW, PIMC, and PICU was US$38.8 (21.1-64.1) vs. US$260.5 (113.7-567.4) vs. 1212.4 (717.6-1609.6) vs. 2501.8 (1771.6-3405.0), respectively: this difference was statistically significant (p<0.001). CONCLUSIONS: The present study helps to further our understanding of the economic burden of pediatric asthma exacerbations requiring hospital attendance among pediatric patients in a MIC.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1016/j.aller.2019.06.015
dc.identifier.issn0301-0546
dc.identifier.urihttps://hdl.handle.net/20.500.12495/2645
dc.language.isoeng
dc.publisherElsevierspa
dc.publisher.journalAllergologia et immunopathologiaspa
dc.relation.ispartofseriesAllergologia et immunopathologia, 0301-0546, Vol 48, Num 2, 2020, pag 142-148spa
dc.relation.urihttps://www.elsevier.es/en-revista-allergologia-et-immunopathologia-105-linkresolver-direct-medical-costs-pediatric-asthma-S0301054619301168
dc.rights.creativecommons2019
dc.rights.localAcceso cerradospa
dc.subject.armarcDesarrollo econĆ³micospa
dc.subject.decsAsmaspa
dc.subject.decsObstrucciĆ³n de las vĆ­as aĆ©reasspa
dc.subject.keywordsAsthma attackspa
dc.subject.keywordsDirect cost itemsspa
dc.subject.keywordsHealth economicsspa
dc.subject.keywordsHospitalization costsspa
dc.subject.keywordsLength of stayspa
dc.titleDirect medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income countryspa
dc.title.translatedDirect medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income countryspa
dc.typearticlespa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localartĆ­culospa

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Archivo en blanco.txt
TamaƱo:
16 B
Formato:
Plain Text
DescripciĆ³n:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
TamaƱo:
1.71 KB
Formato:
Item-specific license agreed upon to submission
DescripciĆ³n:
Descargar

Colecciones

ArtĆ­culos